KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hepatitis c kidneys safe for transplant with antiviral drugs?
Disease control OngoingThis study tests whether kidneys from donors with hepatitis C can be safely given to patients without the virus. After transplant, patients take antiviral medication to prevent infection. The goal is to expand the donor pool and reduce waiting time for kidney transplants.
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Could a new drug free kidney transplant patients from daily pills?
Disease control OngoingThis study tests whether a drug called siplizumab, combined with donor bone marrow cells and mild chemotherapy, can help kidney transplant recipients stop taking lifelong anti-rejection drugs. The goal is for the body to accept the new kidney without needing daily medication. The…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Kidney transplant patients: which drug better protects your new organ?
Disease control OngoingThis study looks at kidney transplant patients who are at least one year post-surgery and currently taking a combination of two immunosuppressants. Researchers want to see if switching to either RaparoBell or Myrept is safer and more effective at preventing organ rejection, graft…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
AI-Powered urine test for transplant rejection study pulled
Knowledge-focused TerminatedThis study aimed to create artificial intelligence models that could diagnose and predict kidney transplant rejection using urine biomarkers, avoiding the need for invasive biopsies. It planned to analyze data from kidney transplant patients followed at Necker Hospital between 20…
Matched conditions: KIDNEY TRANSPLANTATION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
New data tool aims to improve kidney transplant outcomes
Knowledge-focused OngoingThis study looks back at data from 1,891 kidney transplant patients to understand why some transplants fail. Researchers want to create a decision-support system that helps doctors diagnose rejection earlier and choose better treatments. The goal is to improve long-term survival …
Matched conditions: KIDNEY TRANSPLANTATION
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Gene clues could explain who benefits from rejection therapy
Knowledge-focused OngoingThis study looks at gene activity in blood cells from 30 kidney or lung transplant patients who have chronic rejection. Researchers want to find out why some patients improve with a treatment called extracorporeal photopheresis (ECP) while others do not. By comparing gene profile…
Matched conditions: KIDNEY TRANSPLANTATION
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC